Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Primary neurolymphomatosis with MAG antibody: a case report.
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- معلومة اضافية
- المصدر:
Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE
- بيانات النشر:
Original Publication: London : BioMed Central, [2001-
- الموضوع:
- نبذة مختصرة :
Neurolymphomatosis (NL) is a rare neurologic manifestation of non-Hodgkin lymphoma (NHL) with poor prognosis. Investigations including MRI, PET/CT, nerve biopsy and cerebrospinal fluid (CSF) analysis can aid the diagnosis of NL. In this study, we presented a case of NL with co-existing myelin-associated glycoprotein (MAG) antibody. The patient first presented with symptoms of peripheral neuropathy involving multiple cranial nerves and cauda equina, and later developed obstructive hydrocephalus and deep matter lesions. He also had persistently positive MAG antibody, but did not develop electrophysiologically proven neuropathy and monoclonal immunoglobulin. The final brain biopsy confirmed diffuse large B cell lymphoma.
(© 2024. The Author(s).)
- References:
Medicine (Baltimore). 2019 Apr;98(15):e15049. (PMID: 30985655)
J Neurol Sci. 2015 Aug 15;355(1-2):25-36. (PMID: 26070654)
Neurosignals. 2008;16(2-3):226-34. (PMID: 18253060)
Ann Neurol. 1988 Jul;24(1):93-7. (PMID: 2458065)
Semin Immunopathol. 2009 Nov;31(4):497-511. (PMID: 19779720)
J Neuroimmunol. 2021 Dec 15;361:577725. (PMID: 34610502)
J Clin Neurol. 2015 Jul;11(3):283-6. (PMID: 25749823)
J Neuroimmunol. 2011 Jul;236(1-2):99-105. (PMID: 21621858)
Cancer J. 2012 Sep-Oct;18(5):463-8. (PMID: 23006953)
Ann Intern Med. 2022 Dec;175(12):ITC177-ITC192. (PMID: 36508741)
Hematol Oncol. 2019 Dec;37(5):634-637. (PMID: 31657017)
Neurotherapeutics. 2009 Jul;6(3):587-97. (PMID: 19560747)
Neurosci Res. 2015 Feb;91:63-8. (PMID: 25450311)
Blood. 2010 Jun 17;115(24):5005-11. (PMID: 20368468)
Neurobiol Dis. 2013 Jan;49:221-31. (PMID: 22940629)
J Neurol Sci. 2005 Feb 15;228(2):187-9. (PMID: 15694201)
Ann Neurol. 1994 Sep;36(3):416-24. (PMID: 8080249)
Neuro Oncol. 2003 Apr;5(2):104-15. (PMID: 12672282)
Sci Rep. 2019 Apr 16;9(1):6155. (PMID: 30992531)
Brain. 1996 Jun;119 ( Pt 3):775-87. (PMID: 8673490)
Neuro Oncol. 2010 Feb;12(2):212-5. (PMID: 20150388)
Blood Adv. 2021 Mar 9;5(5):1379-1387. (PMID: 33661298)
BMJ Case Rep. 2012 Jun 14;2012:. (PMID: 22707692)
Ann Neurol. 1989 Oct;26(4):543-50. (PMID: 2479332)
Biochim Biophys Acta Gen Subj. 2017 Oct;1861(10):2455-2461. (PMID: 28709864)
- Grant Information:
No.202310152 the Jiangxi Provincial Health Commission science and technology plan; No.2022B563 the Science and Technology Plan of Jiangxi Provincial Administration of Traditional Chinese Medicine
- Contributed Indexing:
Keywords: Cranial neuropathy; MAG antibody; Neurolymphomatosis; Rituximab
- الرقم المعرف:
0 (Myelin-Associated Glycoprotein)
0 (Autoantibodies)
- الموضوع:
Date Created: 20240905 Date Completed: 20240905 Latest Revision: 20241025
- الموضوع:
20250114
- الرقم المعرف:
PMC11375887
- الرقم المعرف:
10.1186/s12883-024-03798-7
- الرقم المعرف:
39237863
No Comments.